These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection. Abdelnabi R; Foo CS; Kaptein SJF; Boudewijns R; Vangeel L; De Jonghe S; Jochmans D; Weynand B; Neyts J J Virol; 2022 Aug; 96(16):e0075822. PubMed ID: 35924921 [TBL] [Abstract][Full Text] [Related]
6. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. Luo J; Zhang Z; Zhao S; Gao R Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047339 [TBL] [Abstract][Full Text] [Related]
8. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets. Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK mBio; 2020 May; 11(3):. PubMed ID: 32444382 [TBL] [Abstract][Full Text] [Related]
9. Antiviral drugs for influenza for 2020-2021. Med Lett Drugs Ther; 2020 Nov; 62(1610):169-172. PubMed ID: 33429402 [No Abstract] [Full Text] [Related]
10. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity. Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D Cells; 2021 Jul; 10(7):. PubMed ID: 34359926 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model. Nobori H; Fukao K; Kuroda T; Anan N; Tashima R; Nakashima M; Noda S; Tajiri M; Torii M; Toba S; Uemura K; Sanaki T; Shishido T; Tachibana Y; Kato T J Antimicrob Chemother; 2022 Oct; 77(11):2984-2991. PubMed ID: 35914182 [TBL] [Abstract][Full Text] [Related]
12. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014 [TBL] [Abstract][Full Text] [Related]
13. Molnupiravir and Its Antiviral Activity Against COVID-19. Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J Front Immunol; 2022; 13():855496. PubMed ID: 35444647 [TBL] [Abstract][Full Text] [Related]
14. Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants. Bojkova D; Stack R; Rothenburger T; Kandler JD; Ciesek S; Wass MN; Michaelis M; Cinatl J J Infect; 2022 Nov; 85(5):573-607. PubMed ID: 35917841 [No Abstract] [Full Text] [Related]
15. Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection. Melano I; Kuo LL; Lo YC; Sung PW; Tien N; Su WC Viruses; 2021 Jul; 13(7):. PubMed ID: 34372507 [TBL] [Abstract][Full Text] [Related]
16. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin. Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371 [TBL] [Abstract][Full Text] [Related]